Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Fabiana Saccheri"'
Autor:
Francesco Menzella, MD, Jocelyne Just, MD, PhD, HDR, Inessa Schwab Sauerbeck, PhD, Claudia Mailaender, PhD, Fabiana Saccheri, PhD, Celine Thonnelier, Pharm D, Xavier Jaumont, MD, Laurence Mala, Pharm D
Publikováno v:
World Allergy Organization Journal, Vol 16, Iss 6, Pp 100787- (2023)
Immunoglobulin E (IgE) plays a critical role in the allergen-initiated inflammatory pathway and thus serves as a viable therapeutic target in allergic or IgE-mediated diseases such as asthma. Omalizumab, an anti-IgE biologic, has been approved in the
Externí odkaz:
https://doaj.org/article/1ee3faee6f3546769426d58a00e6db64
Publikováno v:
Clinical and Translational Allergy, Vol 10, Iss 1, Pp 1-9 (2020)
Abstract Background A significant proportion of patients with severe asthma may also suffer from nasal polyposis, which is commonly defined as chronic rhinosinusitis with nasal polyps (CRSwNP), the presence of which may adversely affect asthma treatm
Externí odkaz:
https://doaj.org/article/7134e7360dd44a7fb0288b2fbfb25294
Autor:
Oliviero Rossi, Angelo Piccirillo, Enrico Iemoli, Annalisa Patrizi, Luca Stingeni, Stefano Calvieri, Massimo Gola, Paolo Dapavo, Antonio Cristaudo, Leonardo Zichichi, Laura Losappio, Fabiana Saccheri, Elide Anna Pastorello
Publikováno v:
World Allergy Organization Journal, Vol 13, Iss 12, Pp 100470- (2020)
Introduction: In Italy, the real-world evidence on the extent of adherence to guidelines and the benefits of recommended therapeutic medications and their impact on the quality of life (QoL) of H1-antihistamines (H1-AH) refractory chronic urticaria (
Externí odkaz:
https://doaj.org/article/a92612a9502944feab987faee035fc91
Autor:
Anna Maria Riccio, Pierluigi Mauri, Laura De Ferrari, Rossana Rossi, Dario Di Silvestre, Marta Bartezaghi, Fabiana Saccheri, Giorgio Walter Canonica
Publikováno v:
World Allergy Organization Journal, Vol 13, Iss 1, Pp - (2020)
Background: Patients with severe allergic asthma (SAA) when treated with omalizumab may exhibit different extent of response. Identifying biomarkers that can predict the extent of treatment effectiveness in patients can be useful in personalizing oma
Externí odkaz:
https://doaj.org/article/e1e6a00975e64443ae129f654fed121e
Publikováno v:
Clinical and Translational Allergy, Vol 10, Iss 1, Pp 1-9 (2020)
Clinical and Translational Allergy
Clinical and Translational Allergy
Background A significant proportion of patients with severe asthma may also suffer from nasal polyposis, which is commonly defined as chronic rhinosinusitis with nasal polyps (CRSwNP), the presence of which may adversely affect asthma treatment outco
Autor:
Rossana Rossi, Anna Maria Riccio, Fabiana Saccheri, Marta Bartezaghi, Giorgio Walter Canonica, Pierluigi Mauri, Laura De Ferrari, Dario Di Silvestre
Publikováno v:
World Allergy Organization Journal, Vol 13, Iss 1, Pp-(2020)
Background: Patients with severe allergic asthma (SAA) when treated with omalizumab may exhibit different extent of response. Identifying biomarkers that can predict the extent of treatment effectiveness in patients can be useful in personalizing oma
Autor:
Laura Michelina Losappio, Fabiana Saccheri, Luca Stingeni, Antonio Cristaudo, Oliviero Rossi, Angelo Piccirillo, Paolo Dapavo, Annalisa Patrizi, Enrico Iemoli, Elide A. Pastorello, L. Zichichi, Stefano Calvieri, Massimo Gola
Publikováno v:
The World Allergy Organization Journal
World Allergy Organization Journal, Vol 13, Iss 12, Pp 100470-(2020)
World Allergy Organization Journal, Vol 13, Iss 12, Pp 100470-(2020)
Introduction In Italy, the real-world evidence on the extent of adherence to guidelines and the benefits of recommended therapeutic medications and their impact on the quality of life (QoL) of H1-antihistamines (H1-AH) refractory chronic urticaria (C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f891ed32753add61c5fcfdfa931564fd
http://hdl.handle.net/11391/1494066
http://hdl.handle.net/11391/1494066
Autor:
Anna Maria, Riccio, Pierluigi, Mauri, Laura, De Ferrari, Rossana, Rossi, Dario, Di Silvestre, Marta, Bartezaghi, Fabiana, Saccheri, Giorgio Walter, Canonica
Publikováno v:
The World Allergy Organization Journal
Background Patients with severe allergic asthma (SAA) when treated with omalizumab may exhibit different extent of response. Identifying biomarkers that can predict the extent of treatment effectiveness in patients can be useful in personalizing omal
Autor:
Giorgio Walter Canonica, Fabiana Saccheri, Pierluigi Mauri, Anna Maria Riccio, Marta Bartezaghi
Publikováno v:
Airway pharmacology and treatment.
Autor:
Laura Rigoni, dario DiSilvestre, Pierluigi Mauri, A. M. Riccio, Giorgio Walter Canonica, Marta Bartezaghi, Rossana Rossi, Fabiana Saccheri
Publikováno v:
Allergy and immunology.
Introduction: PROXIMA study evaluated the effect of omalizumab in severe allergic asthma (SAA) patients. In the context of this study, a sub-study on proteomic analysis of asthma biomarkers was conducted on biological samples of SAA patients. Aim and